Avanos Medical (NYSE:AVNS – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.300-1.350 for the period, compared to the consensus earnings per share estimate of 1.390. The company issued revenue guidance of $683.0 million-$688.0 million, compared to the consensus revenue estimate of $695.2 million.
Avanos Medical Stock Up 0.2 %
Avanos Medical stock traded up $0.03 during mid-day trading on Friday, hitting $18.71. The company’s stock had a trading volume of 441,974 shares, compared to its average volume of 237,900. The firm’s 50 day moving average is $23.23 and its 200 day moving average is $21.48. The company has a market cap of $859.72 million, a PE ratio of 54.94 and a beta of 0.91. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.49. Avanos Medical has a 52-week low of $17.39 and a 52-week high of $25.36.
Avanos Medical (NYSE:AVNS – Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.36 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.36. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. The company had revenue of $170.40 million during the quarter, compared to the consensus estimate of $175.03 million. On average, analysts anticipate that Avanos Medical will post 1.33 earnings per share for the current year.
Analysts Set New Price Targets
Read Our Latest Stock Report on AVNS
About Avanos Medical
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Further Reading
- Five stocks we like better than Avanos Medical
- How to Calculate Options Profits
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- 3 Monster Growth Stocks to Buy Now
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.